SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decrease in Short Interest

SOPHiA GENETICS SA (NASDAQ:SOPH – Get Free Report) was the target of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 28,900 shares, a decrease of 20.2% from the September 30th total of 36,200 shares. Approximately 0.1% of the company’s stock are short sold. […]

Related Keywords

,Jpmorgan Chase Co ,Boothbay Fund Management ,Pricet Rowe Associates Inc ,Citadel Advisors ,Company Profile ,Get Free Report ,Fund Management ,Sophia Genetics ,Nasdaq Soph ,Osoph ,Medical ,Stocks ,Options ,Put ,Call ,